Shrestha Lab at CPDR
Shrestha Lab at CPDR
CPDR
Home
Research
Team
Publications
Software
News
Join us
Contact
ME Gleave
Latest
BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer